Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Punjab, India.
Mutat Res. 2013 Jul 4;755(1):11-23. doi: 10.1016/j.mrgentox.2013.04.013. Epub 2013 May 3.
Testicular damage is a common clinical problem in diabetic individuals that severely affects the quality of life. The present study investigates the possible protective mechanisms of telmisartan, an angiotensin II-receptor antagonist in the germ cell of diabetic rat. Male SD rats were used and randomized into six groups: control, telmisartan control, diabetic control and diabetic group treated with telmisartan at the doses of 3, 6 and 12mg/kg/day, per oral for 4 weeks. Diabetes was induced by injecting a single dose of streptozotocin (STZ), (55mg/kg) dissolved in ice-cold 10mM citrate buffer; pH 4.4 and administered i.p. immediately after preparation to the SD rats. At the end of the study, rats were sacrificed and the levels of nitrite, superoxide, malondialdehyde (MDA), glutathione (reduced and peroxidase) and superoxide dismutase (SOD) were measured. Germ cell toxicity was evaluated by using sperm count, sperm comet assay, histology of testes and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay. Further to confirm the oxidative and nitrosative damage, immunohistological quantification of 8-oxo-dG (8-oxo-7,8-dihydro-2'-deoxyguanosine) and 3-nitrotyrosine were evaluated respectively. Results showed that telmisartan significantly restored the levels of nitrite, superoxide, malondialdehyde, and glutathione and superoxide dismutase in diabetic testes. Further, telmisartan significantly increased the sperm counts, reduced apoptotic cell death, sperm DNA damage, oxidative and nitrosative damage in diabetic rat. Western blot analysis showed that telmisartan reduced the testicular inflammation and cell death by down-regulating the expression of NF-κB, IL-6, TNF-α, p-ERK1/2, iNOS, caspase-3 and increasing the PPAR-γ expression. Results clearly indicate that telmisartan significantly reduced the both oxidative and nitrosative stress, inflammation and cell death in diabetic testes. The present results confirmed that telmisartan exhibited beneficial role in the germ cell of diabetic rat.
睾丸损伤是糖尿病患者常见的临床问题,严重影响生活质量。本研究探讨了血管紧张素 II 受体拮抗剂替米沙坦在糖尿病大鼠生殖细胞中的可能保护机制。雄性 SD 大鼠随机分为六组:对照组、替米沙坦对照组、糖尿病对照组和糖尿病组,分别给予替米沙坦 3、6 和 12mg/kg/天,口服 4 周。糖尿病通过单次注射链脲佐菌素(STZ)(55mg/kg)诱导,溶于冰冷的 10mM 柠檬酸盐缓冲液(pH 4.4),制备后立即腹腔内注射至 SD 大鼠。研究结束时,处死大鼠,测定亚硝酸盐、超氧化物、丙二醛(MDA)、谷胱甘肽(还原型和过氧化物酶)和超氧化物歧化酶(SOD)水平。通过精子计数、精子彗星试验、睾丸组织学和末端脱氧核苷酸转移酶介导的 dUTP 缺口末端标记(TUNEL)试验评估生殖细胞毒性。进一步通过免疫组化定量评估 8-氧代-dG(8-氧代-7,8-二氢-2'-脱氧鸟苷)和 3-硝基酪氨酸来证实氧化和硝化损伤。结果表明,替米沙坦可显著恢复糖尿病睾丸中亚硝酸盐、超氧化物、丙二醛和谷胱甘肽以及超氧化物歧化酶的水平。此外,替米沙坦可显著增加糖尿病大鼠的精子计数,减少凋亡细胞死亡、精子 DNA 损伤、氧化和硝化损伤。Western blot 分析表明,替米沙坦通过下调 NF-κB、IL-6、TNF-α、p-ERK1/2、iNOS、caspase-3 的表达,增加 PPAR-γ 的表达,减少睾丸炎症和细胞死亡。结果清楚地表明,替米沙坦可显著降低糖尿病睾丸中的氧化和硝化应激、炎症和细胞死亡。本研究证实替米沙坦在糖尿病大鼠生殖细胞中具有有益作用。